Incidence of adverse drug reactions in paediatric in/out-patients: A systematic review and meta-analysis of prospective studies

British Journal of Clinical Pharmacology

Volumn 52, Issue 1, 2001, Pages 77-83

  Impicciatore, Piero ^a,b   Choonara, Imti ^a   Clarkson, Amanda ^a   Provasi, Davide ^b   Pandolfini, Chiara ^b   Bonati, Maurizio ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Adverse drug reactions; Child; Meta analysis; Prospective studies; Systematic review

Indexed keywords

ACCURACY; ADVERSE DRUG REACTION; ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; DRUG EXPOSURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH CARE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFORMATION PROCESSING; META ANALYSIS; MONITORING; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; DRUG MONITORING; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; OUTPATIENTS; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0034825508     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01407.x     Document Type: Article

References (43)

1. Pharmacovigilance in the 1990s
2. Adverse drug reactions in children: A systematic review of published case reports
3. Adverse drug reactions in neonatal intensive care units
4. Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use
5. Unlicensed and off-label drug use in paediatric wards in different European countries
6. The registry of clinical trials in children must be set up
7. Drug trials in children: Problems the way forward
8. Meta-analysis and epidemiologic studies in drug development post marketing surveillance
9. Incidence of adverse drug reactions in hospitalized patients A meta-analysis of prospective studies
10. Closing the gap in drug therapy
11. Meta-analysis
12. A random-effects regression model for meta-analysis
13. A prospective study of the epidemiology of adverse drug reactions in pediatric hematology oncology patients
14. Adverse drug reactions in general pediatric outpatients
15. Adverse reactions to drugs in children
16. Adverse drug reactions in pediatrics with a study of in-hospital intensive surveillance
17. A pharmacist based study of the epidemiology of adverse drug reactions in pediatric medicine patients
18. Drug usage and adverse drug reactions in paediatric patients
19. Drug utilisation and reported adverse reactions in hospitalised children
20. Adverse reactions in medical inpatients
21. Reacciones adversas causadas por medicamentos en Pediatria
22. Adverse drug reactions in a paediatric intensive care unit
23. Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study
24. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: A prospective study
25. A prospective study of adverse drug reactions in hospitalized children
26. Adverse drug reactions leading to hospitalization in children
27. Drug related hospitalization in pediatric patients
28. Adverse drug reactions in children leading to hospital admission
29. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital
30. The incidence of drug-related problems as a cause of hospital admissions in children
31. Adverse drug reactions in pediatric outpatients
32. Intensive monitoring of adverse drug reactions in infants and preschool children
33. Active monitoring of adverse drug reactions in children
34. Drug related hospital admissions
35. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine
36. Patient risk factors for adverse drug events in hospitalized patients
37. Drug toxicity and surveillance in children
38. Admission to hospital caused by adverse drug reactions: Cross sectional incidence study
39. Paediatric prescribing: Using unlicensed drugs and medicines outside their licensed indications
40. Epidemiological evaluation of drug use in children
41. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?
42. Better reporting of randomised controlled trials: The CONSORT statement
43. Meta-analysis of observational studies in epidemiology. A proposal for reporting